{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:20:47Z","timestamp":1785892847099,"version":"3.56.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Severe community-acquired pneumococcal meningitis is a medical emergency. The aim of the present investigation was to evaluate the epidemiology, management and outcomes of this condition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This was a retrospective, observational and multicenter cohort study. Sixteen Spanish intensive care units (ICUs) were included. Demographic, clinical and microbiological variables from patients with\n                      <jats:italic>Streptococcus pneumoniae<\/jats:italic>\n                      meningitis admitted to ICU were evaluated. Clinical response was evaluated at 72\u00a0h after antibiotic treatment initiation, and meningitis complications, length of stay and 30-day mortality were also recorded.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In total, 255 patients were included. Cerebrospinal fluid (CSF) culture was positive in 89.7%; 25.7% were non-susceptible to penicillin, and 5.2% were non-susceptible to ceftriaxone or cefotaxime. The most frequent empiric antibiotic regimen was third-generation cephalosporin (47.5%) plus vancomycin (27.8%) or linezolid (12.9%). A steroid treatment regimen was administered to 88.6% of the patients. Clinical response was achieved in 65.8% of patients after 72\u00a0h of antibiotic treatment. Multivariate analysis identified two factors associated with early treatment failure: invasive mechanical ventilation (OR 10.74; 95% CI 3.04\u201337.95,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and septic shock (OR 1.18; 95% CI 1.03\u20131.36,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.017). The 30-day mortality rate was 13.7%. Only three factors were independently associated with 30-day mortality: delay in start of antibiotic treatment (OR 18.69; 95% CI 2.13\u2013163.97,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.008), Sepsis-related Organ Failure Assessment (SOFA) score (OR 1.36; 95% CI 1.12\u20131.66,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002) and early treatment failure (OR 21.75 (3.40\u2013139.18),\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001). Neurological complications appeared in 124 patients (48.63%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Mortality rate in critically ill patients with pneumococcal meningitis is lower than previously reported. Delay in antibiotic treatment following admission is the only amendable factor associated with mortality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-023-04347-3","type":"journal-article","created":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T11:03:06Z","timestamp":1677150186000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Severe community-acquired Streptococcus pneumoniae bacterial meningitis: clinical and prognostic picture from the intensive care unit"],"prefix":"10.1186","volume":"27","author":[{"given":"Mar\u00eda","family":"Mart\u00edn-Cerezuela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maialen","family":"Aseginolaza-Lizarazu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Boronat-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Asensio-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Alam\u00e1n-Laguarda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"\u00c1lvarez-Lerma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Roa-Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Socias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Vera-Art\u00e1zcoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7598-3350","authenticated-orcid":false,"given":"Paula","family":"Ram\u00edrez-Galleymore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Grupo de Trabajo en Infecci\u00f3n y Sepsis (GTEIS) from the Sociedad Espa\u00f1ola de Medicina Intensiva y Unidades Coronarias (SEMICYUC)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1rbara","family":"Balandin-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loreto","family":"Vidaur-Tello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"S\u00e1nchez-Morcillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Ballesteros-Herr\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Ossa-Echeverri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Andaluz-Ojeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel \u00c1ngel","family":"Blasco-Navalpotro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Abella-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonor","family":"Nogales-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emili","family":"D\u00edaz-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriol","family":"Plans-Galv\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Conejo-M\u00e1rquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,23]]},"reference":[{"issue":"3","key":"4347_CR1","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S1473-3099(15)00430-2","volume":"16","author":"MW Bijlsma","year":"2016","unstructured":"Bijlsma MW, Brouwer MC, Kasanmoentalib ES, Kloek AT, Lucas MJ, Tanck MW, van der Ende A, van de Beek D. Community-acquired bacterial meningitis in adults in the Netherlands, 2006\u201314: A prospective cohort study. Lancet Infect Dis. 2016;16(3):339\u2013447.","journal-title":"Lancet Infect Dis"},{"key":"4347_CR2","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1097\/01.CCM.0000239434.26669.65","volume":"34","author":"M Auburtin","year":"2006","unstructured":"Auburtin M, Wolff M, Charpentier J, Varon E, Le Tulzo Y, Girault C, Mohammedi I, Renard B, Mourvillier B, Bruneel F, Ricard JD, Timsit JF. Detrimental role of delayed antibiotic administration and penicillin-nonsusceptible strains in adult intensive care unit patients with pneumococcal meningitis: The PNEUMOREA prospective multicenter study. Crit Care Med. 2006;34:2758\u201365.","journal-title":"Crit Care Med"},{"issue":"1","key":"4347_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ijid.2013.09.012","volume":"19","author":"H Erdem","year":"2014","unstructured":"Erdem H, Elaldi N, \u00d6ztoprak N, Sengoz G, Ak O, Kaya S, Inan A, Nayman-Alpat S, Ulu-Kilic A, Pekok AU, et al. Mortality indicators in pneumococcal meningitis: Therapeutic implications. Int J Infect Dis. 2014;19(1):13\u20139.","journal-title":"Int J Infect Dis"},{"issue":"5","key":"4347_CR4","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1164\/ajrccm.165.5.2105110","volume":"165","author":"M Auburtin","year":"2002","unstructured":"Auburtin M, Porcher R, Bruneel F, Scanvic A, Trouillet JL, B\u00e9dos JP, R\u00e9gnier B, Wolff M. Pneumococcal meningitis in the intensive care unit: Prognostic factors of clinical outcome in a series of 80 cases. Am J Respir Crit Care Med. 2002;165(5):713\u20137.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"4347_CR5","doi-asserted-by":"publisher","first-page":"16074","DOI":"10.1038\/nrdp.2016.74","volume":"3","author":"D van de Beek","year":"2016","unstructured":"van de Beek D, Brouwer M, Hasbun R, Koedel U, Whitney CG, Wijdicks E. Community-acquired bacterial meningitis. Nat Rev Dis Primers. 2016;3(2):16074.","journal-title":"Nat Rev Dis Primers"},{"key":"4347_CR6","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1086\/425368","volume":"39","author":"AR Tunkel","year":"2004","unstructured":"Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, Whitley RJ. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39:1267\u201384.","journal-title":"Clin Infect Dis"},{"key":"4347_CR7","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/S0140-6736(21)00883-7","volume":"398","author":"D van de Beek","year":"2021","unstructured":"van de Beek D, Brouwer MC, Koedel U, Wall EC. Community-acquired bacterial meningitis. Lancet. 2021;398:1171\u201383.","journal-title":"Lancet"},{"issue":"2","key":"4347_CR8","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1016\/j.cmi.2016.01.007","volume":"22","author":"D van de Beek","year":"2016","unstructured":"van de Beek D, Cabellos C, Dzupova O, Esposito S, Klein M, Kloek AT, Leib SL, Mourvillier B, Ostergaard C, Pagliano P, et al. ESCMID guideline: Diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016;22(2):S37-62.","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"4347_CR9","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1007\/s00134-007-0557-7","volume":"33","author":"P Ram\u00edrez","year":"2007","unstructured":"Ram\u00edrez P, Sahuquillo JM, Cort\u00e9s C, Kot P, Bonastre JM. Linezolid as rescue therapy for pneumococcal meningitis. Intensive Care Med. 2007;33(5):924\u20135.","journal-title":"Intensive Care Med"},{"issue":"6","key":"4347_CR10","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.medin.2021.05.011","volume":"46","author":"M Martin-Cerezuela","year":"2022","unstructured":"Martin-Cerezuela M, Padros MA, Piqueres S, Barrios M, Frasquet J, Ramirez P. Ceftaroline versus standard therapy for pneumococcal meningitis in critically ill patients. Med Intensiva. 2022;46(6):348\u201350.","journal-title":"Med Intensiva"},{"key":"4347_CR11","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1056\/NEJMoa021334","volume":"347","author":"J de Gans","year":"2002","unstructured":"de Gans J, van de Beek D. Dexamethasone in Adults with Bacterial Meningitis. N Engl J Med. 2002;347:1549\u201356.","journal-title":"N Engl J Med"},{"key":"4347_CR12","doi-asserted-by":"crossref","unstructured":"Brouwer MC, McIntyre P, Prasad K, van de Beek D. Corticosteroids for acute bacterial meningitis.\u00a0Cochrane Database Syst Rev. 2015;2015(9):CD004405. Published 2015 Sep 12.","DOI":"10.1002\/14651858.CD004405.pub5"},{"issue":"9","key":"4347_CR13","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1007\/s10096-017-2973-0","volume":"36","author":"H Erdem","year":"2017","unstructured":"Erdem H, Inan A, Guven E, Hargreaves S, Larsen L, Shehata G, Pernicova E, Khan E, Bastakova L, Namani S, et al. The burden and epidemiology of community-acquired central nervous system infections: a multinational study. Eur J Clin Microbiol Infect Dis. 2017;36(9):1595\u2013611.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4347_CR14","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/s13054-016-1498-8","volume":"20","author":"G Buchholz","year":"2016","unstructured":"Buchholz G, Koedel U, Pfister HW, Kastenbauer S, Klein M. Dramatic reduction of mortality in pneumococcal meningitis. Crit Care. 2016;20:312.","journal-title":"Crit Care"},{"issue":"9","key":"4347_CR15","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S1473-3099(14)70805-9","volume":"14","author":"RL Castelblanco","year":"2014","unstructured":"Castelblanco RL, Lee M, Hasbun R. Epidemiology of bacterial meningitis in the USA from 1997 to 2010: a population-based observational study. Lancet Infect Dis. 2014;14(9):813\u20139.","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"4347_CR16","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1093\/cid\/civ011","volume":"60","author":"M Glim\u00e5ker","year":"2015","unstructured":"Glim\u00e5ker M, Johansson B, Grindborg \u00d6, Bottai M, Lindquist L, Sj\u00f6lin J. Adult bacterial meningitis: Earlier treatment and improved outcome following guideline revision promoting prompt lumbar puncture. Clin Infect Dis. 2015;60(8):1132\u201369.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"4347_CR17","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/cid\/ciab477","volume":"74","author":"DLH Koelman","year":"2022","unstructured":"Koelman DLH, Brouwer MC, Ter Horst L, Bijlsma MW, van der Ende A, van de Beek D. Pneumococcal Meningitis in Adults: A Prospective Nationwide Cohort Study Over a 20-year Period. Clin Infect Dis. 2022;74(4):657\u201367.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"4347_CR18","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s10096-009-0782-9","volume":"28","author":"H Georges","year":"2009","unstructured":"Georges H, Chiche A, Alfandari S, Devos P, Boussekey N, Leroy O. Adult community-acquired bacterial meningitis requiring ICU admission: epidemiological data, prognosis factors and adherence to IDSA guidelines. Eur J Clin Microbiol Infect Dis. 2009;28(11):1317\u201325.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"4347_CR19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1469-0691.2011.03703.x","volume":"19","author":"R Leclercq","year":"2013","unstructured":"Leclercq R, Cant\u00f3n R, Brown DF, Giske CG, Heisig P, MacGowan AP, Mouton JW, Nordmann P, Rodloff AC, Rossolini GM, et al. EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect. 2013;19(2):141\u201360.","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"4347_CR20","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","volume":"34","author":"A Kumar","year":"2006","unstructured":"Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589\u201396.","journal-title":"Crit Care Med"},{"key":"4347_CR21","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1128\/CMR.00007-10","volume":"4","author":"R Nau","year":"2010","unstructured":"Nau R, S\u00f6rgel F, Eiffert H. Penetration of drugs through the blood-cerebrospinal fluid\/blood-brain barrier for treatment of central nervous system infections. Clin Microbiol Rev. 2010;4:858\u201383.","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"4347_CR22","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1086\/510390","volume":"44","author":"JD Ricard","year":"2007","unstructured":"Ricard JD, Wolff M, Lacherade JC, Mourvillier B, Hidri N, Barnaud G, Chevrel G, Bouadma L, Dreyfuss D. Levels of vancomycin in cerebrospinal fluid of adult patients receiving adjunctive corticosteroids to treat pneumococcal meningitis: a prospective multicenter observational study. Clin Infect Dis. 2007;44(2):250\u20135.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"4347_CR23","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1093\/jac\/46.6.981","volume":"46","author":"P Ottagnoud","year":"2000","unstructured":"Ottagnoud P, Gerber CM, Acosta F, Cottagnoud M, Neftel K, T\u00e4uber MG. Linezolid against penicillin-sensitive and -resistant pneumococci in the rabbit meningitis model. J Antimicrob Chemother. 2000;46(6):981\u20135.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"4347_CR24","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1128\/AAC.04965-14","volume":"59","author":"G Sakoulas","year":"2015","unstructured":"Sakoulas G, Nonejuie P, Kullar R, Pogliano J, Rybak MJ, Nizet V. Examining the use of ceftaroline in the treatment of Streptococcus pneumoniae meningitis with reference to human cathelicidin LL-37. Antimicrob Agents Chemother. 2015;59(4):2428\u201331.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"4347_CR25","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1465-9921-15-6","volume":"15","author":"F Blasi","year":"2014","unstructured":"Blasi F, Ostermann H, Racketa J, Medina J, McBride K, Garau J. on behalf of the REACH study group Early versus later response to treatment in patients with community-acquired pneumonia: analysis of the REACH study. Respir Res. 2014;15(1):6.","journal-title":"Respir Res"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04347-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-023-04347-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04347-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T11:05:31Z","timestamp":1677150331000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-023-04347-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,23]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4347"],"URL":"https:\/\/doi.org\/10.1186\/s13054-023-04347-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2285767\/v1","asserted-by":"object"}]},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,23]]},"assertion":[{"value":"17 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted according to the guidelines of the Declaration of Helsinki and approved by The Spanish Agency of Medicines and Medical Devices (AEMPS) (Protocol number UMI-PEN-2019-01). This work was considered as Postauthorization Study\u00a0with a design other than prospective follow-up (Spanish acronym: EPA-OD). Clinical Research Ethics Committee of the La Fe Hospital reviewed and approved originally the Project and then was approved at each of the participating hospitals. Informed consent was not required due to the research\u2019s method as per the policy of the governmental and local research center.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors are members of Infectious Disease Working Group (GTEIS) of the SEMICYUC. The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"72"}}